Literature DB >> 1643827

The E-Test and Campylobacter jejuni.

C N Baker1.   

Abstract

The E-Test is a recently introduced method for performing antimicrobial susceptibility tests. We compared the E-Test to the broth microdilution test and to the standard agar dilution test by using five antimicrobial agents tested against 55 clinical isolates of Campylobacter jejuni from 11 locations in USA (group 1). Later, we selected 30 strains (group 2), which were more resistant than the original survey isolates. Erythromycin, tetracycline, and ciprofloxacin were tested on both groups of organisms. When the three test methods were compared with each other at +/- 1 log2 dilution, the E-test gave the best overall agreement, with 85% of all strains being within acceptable limits. Category interpretation of erythromycin (drug of choice) results was a problem using current NCCLS guideline breakpoints. For the E-Test and the agar dilution method, 82% of the strains were in the intermediate category; but with the broth microdilution method, only 16.4% of the isolates were interpreted as intermediate. If the susceptible category breakpoint was raised to less than or equal to 2 micrograms/ml, then only 3% of the C. jejuni isolates would be interpreted as intermediate by any of the three methods. Our preference for antimicrobial susceptibility testing of C. jejuni is either E-Test or agar dilution at 42 degrees C for 16 hr.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1643827     DOI: 10.1016/0732-8893(92)90092-8

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  9 in total

1.  Comparison of antimicrobial susceptibility testing of Campylobacter spp. by the agar dilution and the agar disk diffusion methods.

Authors:  Taradon Luangtongkum; Teresa Y Morishita; Amna B El-Tayeb; Aaron J Ison; Qijing Zhang
Journal:  J Clin Microbiol       Date:  2006-11-22       Impact factor: 5.948

2.  Antimicrobial susceptibility testing of 59 strains of Campylobacter fetus subsp. fetus.

Authors:  C Tremblay; C Gaudreau
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

3.  Comparison of broth microdilution, E Test, and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni and Campylobacter coli.

Authors:  Petra Luber; Edda Bartelt; Elke Genschow; Jutta Wagner; Helmut Hahn
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

4.  Indwelling device-related bacteremia caused by serum-susceptible Campylobacter coli.

Authors:  P R Hsueh; L J Teng; P C Yang; S W Ho; K T Luh
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

5.  Investigation of Antimicrobial Susceptibilities and Resistance Genes of Campylobacter Isolates from Patients in Edirne, Turkey.

Authors:  Canan Eryıldız; Nermin Sakru; Gülcan Kuyucuklu
Journal:  Iran J Public Health       Date:  2022-03       Impact factor: 1.479

6.  Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.

Authors:  J Engberg; F M Aarestrup; D E Taylor; P Gerner-Smidt; I Nachamkin
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

7.  Effects of diet formulations containing proteins from different sources on intestinal colonization by Campylobacter jejuni in broiler chickens.

Authors:  Roy S Udayamputhoor; Harry Hariharan; Ted A Van Lunen; P Jeffrey Lewis; Susan Heaney; Lawrence Price; David Woodward
Journal:  Can J Vet Res       Date:  2003-07       Impact factor: 1.310

8.  Comparison of agar dilution and E-test for antimicrobial susceptibility testing of Campylobacter coil isolates recovered from 80 Ontario swine farms.

Authors:  Norma P Varela; Robert Friendship; Cate Dewey; Alfonso Valdivieso
Journal:  Can J Vet Res       Date:  2008       Impact factor: 1.310

9.  Antimicrobial resistance among Campylobacter strains, United States, 1997-2001.

Authors:  Amita Gupta; Jennifer M Nelson; Timothy J Barrett; Robert V Tauxe; Shannon P Rossiter; Cindy R Friedman; Kevin W Joyce; Kirk E Smith; Timothy F Jones; Marguerite A Hawkins; Belershacew Shiferaw; James L Beebe; Duc J Vugia; Terry Rabatsky-Ehr; James A Benson; Timothy P Root; Frederick J Angulo
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.